Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Pombiliti, cipaglucosidase alfa, Glycogen Storage Disease Type II, Date of authorisation: 20/03/2023, Status: Authorised
TO: